Glaukos (GKOS) vs Lumexa Imaging (LMRI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Glaukos is the larger company by market cap ($9.51 billion vs $992.5 million), about 9.6 times the size. On valuation, Lumexa Imaging trades at a lower forward P/E (11.6x vs 307.6x for Glaukos).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GKOS | LMRI |
|---|---|---|
| Share price | $161.29 | $10.33 |
| Market cap | $9.51B | $992.45M |
| 1-day change | -6.32% | -2.46% |
| YTD return | +42.85% | -44.16% |
| 1-year return | +84.14% | — |
| 5-year return | +259.86% | — |
| Forward P/E | 307.61 | 11.61 |
| EPS (TTM) | $-3.26 | $-0.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $507.44M | — |
| Revenue growth (YoY) | +32.33% | — |
| Net income (latest FY) | $-187.69M | — |
| Gross margin | 55.72% | — |
| Operating margin | -39.33% | — |
| Net margin | -36.99% | — |
| 52-week high | $191.62 | $19.45 |
| 52-week low | $73.16 | $6.45 |
| Distance from 52-week high | -15.83% | -46.89% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +23.19% | +71.06% |
| Average volume | 831.71K | 430.76K |
| Shares outstanding | 58.98M | 96.07M |
| Employees | 1,094 | 5,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Glaukos is about 9.6 times larger than Lumexa Imaging by market value ($9.51B vs $992.45M).
About Glaukos
GKOS stock →Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor.
Health Care · Medical/Dental Instruments · 1,094 employees
About Lumexa Imaging
LMRI stock →Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States.
Health Care · Medical Specialities · 5,000 employees
GKOS vs LMRI FAQ
Which is bigger, Glaukos or Lumexa Imaging?
Glaukos (GKOS) is larger, with a market capitalization of $9.51B compared with $992.45M for Lumexa Imaging (LMRI).
Are Glaukos and Lumexa Imaging in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Glaukos and Medical Specialities for Lumexa Imaging.